A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Dexcom Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 485,502 shares of DXCM stock, worth $39 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
485,502
Previous 291,514 66.55%
Holding current value
$39 Million
Previous $33.1 Million 1.52%
% of portfolio
0.08%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$64.0 - $116.06 $12.4 Million - $22.5 Million
193,988 Added 66.55%
485,502 $32.5 Million
Q2 2024

Jul 29, 2024

BUY
$110.31 - $140.45 $7.03 Million - $8.95 Million
63,715 Added 27.97%
291,514 $33.1 Million
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $11.1 Million - $13.6 Million
96,839 Added 73.95%
227,799 $31.6 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $780,038 - $1.28 Million
-10,333 Reduced 7.31%
130,960 $16.3 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $6.1 Million - $9.77 Million
70,867 Added 100.63%
141,293 $13.2 Million
Q2 2023

Aug 08, 2023

SELL
$112.47 - $130.98 $14.1 Million - $16.4 Million
-124,941 Reduced 63.95%
70,426 $9.05 Million
Q1 2023

May 08, 2023

SELL
$104.0 - $122.92 $691,496 - $817,295
-6,649 Reduced 3.29%
195,367 $22.7 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $7.85 Million - $11.3 Million
-92,422 Reduced 31.39%
202,016 $22.9 Million
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $1.26 Million - $1.55 Million
16,453 Added 5.92%
294,438 $23.7 Million
Q2 2022

Aug 04, 2022

BUY
$67.99 - $132.89 $14 Million - $27.4 Million
206,150 Added 286.98%
277,985 $20.7 Million
Q1 2022

May 12, 2022

BUY
$94.08 - $130.2 $2.49 Million - $3.45 Million
26,460 Added 58.31%
71,835 $36.8 Million
Q4 2021

Feb 09, 2022

SELL
$129.87 - $162.82 $75,714 - $94,924
-583 Reduced 1.27%
45,375 $24.4 Million
Q3 2021

Nov 08, 2021

SELL
$106.71 - $143.18 $53,248 - $71,446
-499 Reduced 1.07%
45,958 $25.1 Million
Q2 2021

Aug 05, 2021

BUY
$80.99 - $107.93 $3.39 Million - $4.52 Million
41,838 Added 905.78%
46,457 $19.8 Million
Q1 2021

May 05, 2021

SELL
$84.79 - $104.74 $6,444 - $7,960
-76 Reduced 1.62%
4,619 $1.66 Million
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $19,656 - $26,334
252 Added 5.67%
4,695 $1.74 Million
Q3 2020

Nov 09, 2020

SELL
$95.51 - $112.95 $169,148 - $200,034
-1,771 Reduced 28.5%
4,443 $1.83 Million
Q2 2020

Aug 04, 2020

SELL
$62.68 - $105.34 $2.51 Million - $4.22 Million
-40,043 Reduced 86.57%
6,214 $2.52 Million
Q1 2020

May 12, 2020

BUY
$47.79 - $75.63 $752,310 - $1.19 Million
15,742 Added 51.59%
46,257 $12.5 Million
Q4 2019

Feb 11, 2020

BUY
$36.62 - $57.29 $11,315 - $17,702
309 Added 1.02%
30,515 $6.68 Million
Q3 2019

Nov 12, 2019

BUY
$35.53 - $43.8 $987,485 - $1.22 Million
27,793 Added 1151.8%
30,206 $4.51 Million
Q2 2019

Aug 02, 2019

SELL
$27.84 - $38.92 $1.97 Million - $2.75 Million
-70,766 Reduced 96.7%
2,413 $362,000
Q1 2019

Apr 26, 2019

BUY
$28.07 - $38.18 $202,468 - $275,392
7,213 Added 10.93%
73,179 $8.72 Million
Q4 2018

Feb 13, 2019

SELL
$26.99 - $37.37 $4.68 Million - $6.48 Million
-173,306 Reduced 72.43%
65,966 $7.8 Million
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $4.1 Million - $6.44 Million
-175,414 Reduced 42.3%
239,272 $34.2 Million
Q2 2018

Aug 01, 2018

BUY
$17.54 - $25.22 $215,391 - $309,701
12,280 Added 3.05%
414,686 $39.4 Million
Q1 2018

May 07, 2018

SELL
$13.06 - $18.54 $1.68 Million - $2.38 Million
-128,337 Reduced 24.18%
402,406 $29.8 Million
Q4 2017

Feb 01, 2018

BUY
$11.12 - $15.38 $2.2 Million - $3.04 Million
197,612 Added 59.32%
530,743 $30.5 Million
Q3 2017

Nov 02, 2017

BUY
$11.36 - $18.98 $3.78 Million - $6.32 Million
333,131
333,131 $16.3 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.